N.Y. Comp. Codes R. & Regs. Tit. 8 § 60.14 - Non-patient specific orders to dispense self-administered hormonal contraceptives
(a) As used in
this section, self-administered hormonal contraceptives means self-administered
oral hormonal contraceptive medications or devices approved by the federal Food
and Drug Administration to prevent pregnancy by using hormones to regulate or
prevent ovulation, and includes oral hormonal contraceptives, hormonal
contraceptive vaginal rings and hormonal contraceptive patches.
(b) A licensed physician may issue a written
non-patient specific order and protocol for a licensed pharmacist to dispense
self-administered hormonal contraceptives to patients in New York State,
provided that the requirements of this section are met.
(c) Order and protocol.
(1) The non-patient specific order shall
include, at a minimum, the following:
(i) the
name, license number and signature of the licensed physician who issues the
non-patient specific order and protocol;
(ii) the name and dose of the specific
drug(s) or the name of specific medical device to be dispensed;
(iii) a protocol for dispensing the
self-administered hormonal contraceptives or a specific reference to a separate
written protocol for dispensing the self-administered hormonal contraceptives,
which shall meet the requirements of paragraph (2) of subdivision (c) of this
section;
(iv) the period of time
that the order is effective, including the beginning and ending
dates;
(v) a description of the
group(s) of persons who may receive the dispensed self-administered hormonal
contraceptives; and
(vi) the name
and license number of each licensed pharmacist authorized to execute the
non-patient specific order and protocol or the name and address of the New York
State licensed pharmacy that employs or contracts with the licensed
pharmacist(s) to execute the non-patient specific order and protocol.
(2) The written protocol,
incorporated into the order prescribed in paragraph (1) of subdivision (c) of
this section shall, at a minimum, require the licensed pharmacist to:
(i) provide the patient with a self-screening
risk assessment questionnaire, developed by the commissioner of health in
consultation with the commissioner, to be reviewed by the pharmacist to
identify any known risk factors and assist the patient's selection of an
appropriate self-administered hormonal contraceptive;
(ii) provide the patient with a fact sheet,
developed by the commissioner of health, that includes but is not limited to,
the clinical considerations and recommendations for use of the
self-administered hormonal contraceptive, the appropriate method for using such
self-administered hormonal contraceptive, information on the importance of
follow-up health care, health care referral information, and the ability of the
patient to opt out of practitioner reporting requirements;
(iii) notify the patient's primary health
care practitioner, unless the patient opts out of such notification, within
seventy-two hours of dispensing a self-administered hormonal contraceptive,
that such self-administered hormonal contraceptive has been dispensed. Such
notification may occur via electronic transmission or facsimile. If the patient
does not have a primary health care practitioner or is unable to provide
contact information for their primary health care practitioner, the pharmacist
shall provide the patient with a written record of the self-administered
hormonal contraceptives dispensed and advise the patient to consult an
appropriate health care practitioner;
(iv) offer or provide in writing, the names
and addresses of hospitals or other health providers that offer follow-up care,
which shall be identified in the protocol; and
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.